These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Substitution of a single residue in Stichodactyla helianthus peptide, ShK-Dap22, reveals a novel pharmacological profile. Middleton RE; Sanchez M; Linde AR; Bugianesi RM; Dai G; Felix JP; Koprak SL; Staruch MJ; Bruguera M; Cox R; Ghosh A; Hwang J; Jones S; Kohler M; Slaughter RS; McManus OB; Kaczorowski GJ; Garcia ML Biochemistry; 2003 Nov; 42(46):13698-707. PubMed ID: 14622016 [TBL] [Abstract][Full Text] [Related]
8. Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. Garcia-Calvo M; Leonard RJ; Novick J; Stevens SP; Schmalhofer W; Kaczorowski GJ; Garcia ML J Biol Chem; 1993 Sep; 268(25):18866-74. PubMed ID: 8360176 [TBL] [Abstract][Full Text] [Related]
9. Ultrasensitive pharmacological characterisation of the voltage-gated potassium channel K(V)1.3 studied by single-molecule fluorescence microscopy. Freudenthaler G; Axmann M; Schindler H; Pragl B; Knaus HG; Schütz GJ Histochem Cell Biol; 2002 Mar; 117(3):197-202. PubMed ID: 11914916 [TBL] [Abstract][Full Text] [Related]
10. WIN 17317-3, a new high-affinity probe for voltage-gated sodium channels. Wanner SG; Glossmann H; Knaus HG; Baker R; Parsons W; Rupprecht KM; Brochu R; Cohen CJ; Schmalhofer W; Smith M; Warren V; Garcia ML; Kaczorowski GJ Biochemistry; 1999 Aug; 38(34):11137-46. PubMed ID: 10460170 [TBL] [Abstract][Full Text] [Related]
11. Chemical synthesis and structure-function studies of margatoxin, a potent inhibitor of voltage-dependent potassium channel in human T lymphocytes. Bednarek MA; Bugianesi RM; Leonard RJ; Felix JP Biochem Biophys Res Commun; 1994 Jan; 198(2):619-25. PubMed ID: 8297371 [TBL] [Abstract][Full Text] [Related]
12. The 'functional' dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels. Mouhat S; Mosbah A; Visan V; Wulff H; Delepierre M; Darbon H; Grissmer S; De Waard M; Sabatier JM Biochem J; 2004 Jan; 377(Pt 1):25-36. PubMed ID: 12962541 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2. Jäger H; Grissmer S Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028 [TBL] [Abstract][Full Text] [Related]
14. Di-substituted cyclohexyl derivatives bind to two identical sites with positive cooperativity on the voltage-gated potassium channel, K(v)1.3. Schmalhofer WA; Slaughter RS; Matyskiela M; Felix JP; Tang YS; Rupprecht K; Kaczorowski GJ; Garcia ML Biochemistry; 2003 Apr; 42(16):4733-43. PubMed ID: 12705837 [TBL] [Abstract][Full Text] [Related]
16. Complex subunit assembly of neuronal voltage-gated K+ channels. Basis for high-affinity toxin interactions and pharmacology. Koch RO; Wanner SG; Koschak A; Hanner M; Schwarzer C; Kaczorowski GJ; Slaughter RS; Garcia ML; Knaus HG J Biol Chem; 1997 Oct; 272(44):27577-81. PubMed ID: 9346893 [TBL] [Abstract][Full Text] [Related]
17. Margatoxin-bound quantum dots as a novel inhibitor of the voltage-gated ion channel Kv1.3. Schwartz AB; Kapur A; Wang W; Huang Z; Fardone E; Palui G; Mattoussi H; Fadool DA J Neurochem; 2017 Feb; 140(3):404-420. PubMed ID: 27861889 [TBL] [Abstract][Full Text] [Related]
18. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits. Mourre C; Chernova MN; Martin-Eauclaire MF; Bessone R; Jacquet G; Gola M; Alper SL; Crest M J Pharmacol Exp Ther; 1999 Dec; 291(3):943-52. PubMed ID: 10565809 [TBL] [Abstract][Full Text] [Related]